ZOMETA® (Zoledronic Acid) for Prevention of Bone Metastases

Summary

To determine if therapy with Zometa® (zoledronic acid) 4mg will be effective in preventing the occurrence of bone metastases in prostate cancer patients at high risk of developing them. In addition, pain and analgesic scores and overall safety are to be evaluated throughout the study.

Timeline

Start

2003-12

Primary completion

2003-12

Completion

2007-11

Drugs

Indications